| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.2B | $2.8B | $3.9B | $15.1B | $12.8B | $3.2B | $3.0B | $2.8B |
| Cost of Revenue | $7.9B | $6.7B | $9.8B | $9.7B | $7.7B | $7.1B | $6.6B | $6.3B |
| Gross Profit | $3.4B | $1.0B | $1.5B | $5.4B | $5.1B | $1.2B | $1.3B | $1.2B |
| R&D Expense | $0.5B | $0.6B | $0.7B | $0.6B | $0.5B | $0.5B | $0.6B | $0.7B |
| SG&A Expense | $2.9B | $3.0B | $3.9B | $3.9B | $2.9B | $2.5B | $2.5B | $2.6B |
| Operating Income | $-0.3B | $0.0B | $0.4B | $-1.9B | $1.7B | $1.6B | $1.8B | $1.6B |
| Net Income | $-1.0B | $-0.5B | $0.2B | $-2.4B | $1.3B | $0.2B | $-0.0B | $0.3B |
| EPS (Basic) | $-1.87 | $-1.00 | $0.48 | $-4.83 | $2.56 | $0.33 | $-0.05 | $0.66 |
| EPS (Diluted) | $-1.87 | $-1.00 | $0.48 | $-4.83 | $2.53 | $0.33 | $-0.05 | $0.65 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $20.1B | $25.8B | $28.3B | $28.3B | $33.5B | $20.0B | $18.2B | $15.6B |
| Current Assets | $6.9B | $8.9B | $9.6B | $8.0B | $8.9B | $8.4B | $7.5B | $5.9B |
| Cash & Equivalents | $2.0B | $1.8B | $3.2B | $1.7B | $3.0B | $3.7B | $3.3B | $1.8B |
| Total Liabilities | $14.0B | $18.8B | $19.8B | $22.4B | $24.4B | $11.3B | $10.3B | $7.8B |
| Current Liabilities | $3.0B | $6.5B | $6.5B | $4.7B | $4.2B | $3.3B | $3.2B | $2.8B |
| Stockholders' Equity | $6.1B | $7.0B | $8.4B | $5.8B | $9.1B | $8.7B | $7.9B | $7.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.8B | $1.0B | $1.7B | $1.2B | $2.2B | $1.9B | $2.1B | $2.1B |
| Investing Cash Flow | $2.8B | $-0.6B | $3.2B | $-0.9B | $-11.2B | $-1.2B | $-1.1B | $-0.9B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-4.2B | $-1.1B | $-3.5B | $-1.4B | $8.2B | $-0.3B | $0.5B | $-2.6B |